Analysis

China-US Biotech Dealmaking Likely Safe From Tariff Turmoil

By Yeji Jesse Lee · May 6, 2025, 11:47 AM EDT

A new hot spot for biotech dealmaking likely won't cool in the coming months, even as the Trump administration's trade policies and economic uncertainty throws cold water on other areas of...

To view the full article, register now.